Tracy Staton

Editor in Chief, @FierceBiotech, @FierceHealth and @FiercePharma. Write always, edit everything, run with dogs, ski the East

[FierceBiotech @FierceBiotech]

Live from BIO 2022! Here's a short excerpt from @maxonwifi's sit-down interview with @BayerPharma president @guth_sebastian.

[FierceBiotech @FierceBiotech]

BIO returns in-person with biotechs, Big Pharmas looking to make real life connections to survive bear market, @maxonwifi reports from San Diego #BIO2022
https://t.co/fkGRbVnsBD

[Tracy Staton @TracyStaton]

Nice interview with FDA's Richard Pazdur from @FierceBiotech and @Angus_Fierce as we head into #AACR2022 this weekend.

[FierceBiotech @FierceBiotech]

Check out our exclusive interview with FDA oncology chief Richard Pazdur: “People want to take risks in oncology. I’ve been through this with family members and friends; it’s like ‘Doc, give it to me.’” #acceleratedapproval #oncology
https://t.co/PQVaIIkyGd

[Tracy Staton @TracyStaton]

One of my favorite parts of @FiercePharma's drug name Madness is the "sounds like" critiques from our readers. Airport wifi, fire-breathing dragon, Megan Thee Stallion duet partner ... and more.

[FiercePharma @FiercePharma]

Even if your pick doesn't win #FierceMadness, we're sharing our favorite comments from voters here in our Fierce Hall of Fame. Check out the comments below, and ICYMI here's our running coverage of this year's challenge. https://t.co/BICTyXSxyz

[David Feinberg (he/him) @dtfeinberg]

Lots of incredible healthcare leaders on @FierceHealth's Bracket. You can submit your #FierceMadness votes here.
https://t.co/LEBcHRnoNg

[Tracy Staton @TracyStaton]

Last day to vote in this round of @FiercePharma's 2022 #FierceMadness drug name tournament! Check out the bracket below and then vote here: https://t.co/LCNYReHdvu

[Tracy Staton @TracyStaton]

Really proud of the biotech, healthcare and pharma editorial teams here at Fierce. We have a raft of finalist nods in the Neal awards, plus more in the Azbees. Check out both threads below for the stories and news coverage that rated.

[FierceBiotech @FierceBiotech]

But that's not all! Fierce Biotech has also been named as a finalist for 2 Jesse H. Neal Awards, including Best Media Brand in the Overall Editorial Excellence category! https://t.co/An1s7MMT4N

[FierceBiotech @FierceBiotech]

Fierce Biotech has been named as a finalist for 3 regional and 2 national Azbee Awards of Excellence! See our award-winning coverage below
https://t.co/fDgSR0BnFt

[Robert Howard @ProfRobHoward]

It’s deja vu all over again. These are the questions that the FDA Advisory Committee unanimously decided more than a year ago had not been answered for aducanumab. The FDA’s accelerated approval has been a pointless disaster for people with Alzheimer’s and our Field.

[Allison Gatlin @IBD_AGatlin]

$ABBV is down 10% after the FDA said makers of JAK inhibitors must add warnings of heart conditions, blood clots, cancer and death to their labels. This also impacts $PFE and $LLY. This doesn't pertain to drugs from $INCY and $BMY, however.

[Vivian Wang @vwang3]

Update on the elephants: they are still on the outskirts of Kunming, and have the most adorable sleeping formation

[Tracy Staton @TracyStaton]

Dog lovers and word lovers -- you have to read this @FierceMedTech story. https://t.co/fHkWu1hACx

[Brad Loncar @bradloncar]

New rule....investors start preferring public AdComs. No more cheering when a drug doesn't get one. It's the strongest part of the regulatory process that brings out truth. Keeps companies honest.

[Prof Peter Hotez MD PhD DSc(hon) @PeterHotez]

My 5 "perfect storm" worries for Texas:
1. "No vaccines" we still haven't picked up the pace post Ice Harvey, ranking near bottom for vaccinations.
2. No masks
3. Rising B..1.1.7 variant based on new Houston Health wastewater data.
4. Slight rise in positivity
5. Spring Break

[Tracy Staton @TracyStaton]

@RebZam @ohheyjenna Our newsroom is expanding. Scouting for a half-dozen smart journalists who'd like to make a difference covering the science and business of the pandemic. Medtech, biotech, pharma, healthcare. #journojobs posts link below, or DM me. https://t.co/pZxDDqbmO7

[Tracy Staton @TracyStaton]

Lots of Moderna news yesterday/today: booster shot study, new production targets, CMO exit and $18 billion in expected COVID vaccine sales this year. Up from about $11 billion they projected just last month.
https://t.co/Dmu4MATB4N

[Tracy Staton @TracyStaton]

Scouting for smart journalists who'd like to make a difference covering the science and business of the pandemic. Medtech, biotech, pharma—we're an ambitious and growing team. #journojobs posts link below, or DM me: https://t.co/z0Ak0DOIgW

[Tracy Staton @TracyStaton]

Trending on Fierce Pharma (still)—$LLY and its #diabetes candidate posing a potential threat to Novo's star Ozempic https://t.co/HDpCspBs2f

[Adam J. Fein @DrugChannels]

Yikes! The number of clinical trials for #oncology #drugs dropped by 60% during #COVID19 pandemic period @Medidata @JAMANetworkOpen

https://t.co/laGzvXcf3g

Fewer new therapies will be launched in coming years. That's the wrong way to curb drug spending.

[steve usdin @steveusdin1]

The White House has resumed the search for a permanent FDA commissioner in the face of opposition from D senators to Janet Woodcock. A final decision has not been made, but Woodcock's chances are slipping. Josh Sharfstein, is no longer being considered. https://t.co/dgEK5zDV2F